-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Atara Biotherapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2016 to 2023.
- Atara Biotherapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was $14.7M.
- Atara Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $124M, a 39% decline from 2022.
- Atara Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $203M, a 812% increase from 2021.
- Atara Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $22.3M.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)